|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
RXi Pharmaceuticals Corporation
| | | Phone: | (508) 767-3861 | Fax: | (508) 767-3862 | Year Established: | 2003 | Ticker: | RXII | Exchange: | NASDAQ | Main Contact: | Gerrit Dispersyn, Dr. Med. Sc., CDO | | Other Contacts: | Karen Bulock, Ph.D., VP, Research Geert Cauwenbergh, Dr. Med. Sc., President & CEO
| | Company Description | RXi Pharmaceuticals (formerly Argonaut Pharmaceuticals) is a clinical-stage company developing innovative therapeutics that address significant unmet medical needs. Building on the pioneering discovery of RNAi, scientists at RXi have harnessed the naturally occurring RNAi process which can be used to "silence" or down-regulate the expression of a specific gene that may be overexpressed in a disease condition. | |
|
|
|
|
|